Meniscus allograft transplantation: indications, techniques and outcomes
Date
2019
Type:
Article
item.page.extent
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
British Editorial Society of Bone & Joint Surgery
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
New indications for meniscal allograft transplantation (MAT) are being added, but the general expert opinion is that it is still a procedure reserved for symptomatic meniscal loss.
Lateral MAT has better clinical outcomes and less failure risk compared to medial MAT.
Ideal conditions (low-grade chondral lesions) make MAT a more survivable and successful procedure.
Meniscal extrusion after MAT is common and does not seem to alter results.
Midterm survivorship of a MAT is reported to be 85–90%, while long-term survivorship decreases to 50–70% depending on chondral status and concomitant procedures.
Even if the procedure is a success, there are high possibilities of not being able to resume sports activities.
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
EFORT Open Rev 2019;4:115-120. DOI: 10.1302/2058-5241.4.180052
Keywords
Allograft, MAT, Meniscal, Menisectomy, Post-menisectomy syndrome, Transplantation